Jazz Pharmaceuticals plc SEC filings JAZZ
Jazz Pharmaceuticals plc has 1,002 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2025 | — |
| SC TO-T/A | Filing | Apr 18, 2025 | — |
| SC TO-T/A | Filing | Apr 14, 2025 | — |
| SC TO-T/A | Filing | Apr 11, 2025 | — |
| SC TO-T/A | Filing | Apr 10, 2025 | — |
| SC TO-T/A | Filing | Apr 9, 2025 | — |
| SC TO-T/A | Filing | Apr 7, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| SC TO-T/A | Filing | Apr 4, 2025 | — |
| SC TO-T/A | Filing | Apr 1, 2025 | — |
| SC TO-T/A | Filing | Mar 28, 2025 | — |
| SC TO-T | Filing | Mar 21, 2025 | — |
| SC TO-C | Filing | Mar 6, 2025 | — |
| SC TO-C | Filing | Mar 5, 2025 | — |
| SC TO-C | Filing | Mar 5, 2025 | — |
| SC TO-C | Filing | Mar 5, 2025 | — |
| CT ORDER | Filing | Jul 11, 2023 | — |
| DFAN14A | Filing | Apr 20, 2021 | — |
| DFAN14A | Filing | Mar 23, 2021 | — |
| DFAN14A | Filing | Feb 26, 2021 | — |
| DFAN14A | Filing | Feb 24, 2021 | — |
| DFAN14A | Filing | Feb 24, 2021 | — |
| DFAN14A | Filing | Feb 24, 2021 | — |
| DFAN14A | Filing | Feb 23, 2021 | — |
| DFAN14A | Filing | Feb 9, 2021 | — |
| DFAN14A | Filing | Feb 8, 2021 | — |
| DFAN14A | Filing | Feb 5, 2021 | — |
| DFAN14A | Filing | Feb 4, 2021 | — |
| DFAN14A | Filing | Feb 4, 2021 | — |
| DFAN14A | Filing | Feb 4, 2021 | — |
| DFAN14A | Filing | Feb 4, 2021 | — |
| DFAN14A | Filing | Feb 3, 2021 | — |
| CT ORDER | Filing | Jun 30, 2020 | — |
| CT ORDER | Filing | Jun 30, 2020 | — |
| CT ORDER | Filing | Mar 30, 2020 | — |
| CT ORDER | Filing | Mar 30, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2020 | — |
| CORRESP | Letter to the SEC | Feb 14, 2020 | — |
| CORRESP | Letter to the SEC | Jan 17, 2020 | — |
| CORRESP | Letter to the SEC | Dec 20, 2019 | — |
| CORRESP | Letter to the SEC | Nov 19, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2019 | — |
| CT ORDER | Filing | Jul 5, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2018 | — |
| CORRESP | Letter to the SEC | Nov 14, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2018 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| CT ORDER | Filing | Mar 27, 2018 | — |
| CT ORDER | Filing | Sep 11, 2017 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JAZZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1232524
- Former names
- JAZZ PHARMACEUTICALS INC (until Jan 18, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.